Cargando…
解析PD-1/PD-L1抑制剂分子结构差异与不良反应的相关性
As a new method, immunotherapy which is targeting programmed cell death protein 1 (PD-1) and programmed cell death ligand 1 (PD-L1) plays a more and more important role in the treatment of malignant tumors. Immunotherapy is more effective than traditional chemotherapy. However, there are also many a...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406435/ https://www.ncbi.nlm.nih.gov/pubmed/32702794 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.102.17 |